Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
about
Lipid peroxidation: pathophysiological and pharmacological implications in the eyeThe importance of antioxidants which play the role in cellular response against oxidative/nitrosative stress: current stateLipoprotein-associated oxidative stress: a new twist to the postprandial hypothesisOxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness.History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.Adaptive regression modeling of biomarkers of potential harm in a population of U.S. adult cigarette smokers and nonsmokers.The isoprostanes--25 years laterExercise training, NADPH oxidase p22phox gene polymorphisms, and hypertension.Oxidized LDL: diversity, patterns of recognition, and pathophysiology.Consumption of a high glycemic load but not a high glycemic index diet is marginally associated with oxidative stress in young women.Inducible nitric oxide synthase regulates production of isoprostanes in vivo during chlamydial genital infection in mice.Targeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.Increased urinary 15-F2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress.Aspirin: pharmacology and clinical applicationsApplication of gas chromatography-mass spectrometry for analysis of isoprostanes: their role in cardiovascular disease.Exhaled breath condensate in children: pearls and pitfalls.Isoprostanes: novel bioactive products of lipid peroxidation.Inverse correlation between serum adiponectin and 8-iso-prostaglandin F2α in newly diagnosed type 2 diabetes patients.Biomarkers of Alzheimer disease in plasmaIdentification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis.Increased levels of the oxidative stress biomarker 8-iso-prostaglandin F2α in wastewater associated with tobacco useInvestigate the Role of Glutathione S Transferase (GST) Polymorphism in Development of Hypertension in UAE PopulationReactive oxygen species: influence on cerebral vascular tone.Pre-eclampsia: contribution of maternal constitutional factors and the consequences for cardiovascular health.Hypertension and oxidative stress.Soy foods and urinary isoprostanes: results from a randomized study in premenopausal womenOxidative stress as a mechanism of valproic acid-associated hepatotoxicity.Increased oxidative stress in patients with depression and its relationship to treatment.Non-aqueous microchip electrophoresis for characterization of lipid biomarkersAdherence to cancer prevention recommendations and antioxidant and inflammatory status in premenopausal womenHigh-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trialMarkers of oxidant stress that are clinically relevant in aging and age-related diseaseOxidative stress and potential interventions to reduce oxidative stress in overweight and obesity.Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposureCharacterization of isoprostane signaling: evidence for a unique coordination profile of 8-iso-PGF(2alpha) with the thromboxane A(2) receptor, and activation of a separate cAMP-dependent inhibitory pathway in human plateletsMarkers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per dayAirway biomarkers of the oxidant burden in asthma and chronic obstructive pulmonary disease: current and future perspectives.Oxidative stress in fibromyalgia and its relationship to symptomsOxidative stress and insulin resistance: the coronary artery risk development in young adults study.F(2)-isoprostanes as novel biomarkers for type 2 diabetes: a review.
P2860
Q21129236-B1F992F6-08F1-4768-B358-95BB70CDA475Q26741668-C7D95C2D-01A4-4F37-BF1B-DA225EAE714BQ26828643-5C32C9CC-1D71-4F52-A029-741A76E2D21EQ33333142-4827DD00-FAB3-4526-82DB-9B09D849FA6AQ33462295-649E1A40-3D91-4C46-BB7F-F6CC9940499CQ33541268-53CD784D-D860-47C1-9E53-E42BA63EC35BQ33601352-C313B692-B6F4-43D0-A368-ABFB8D2B07B3Q33854261-445A3A86-4281-4BD2-8BDA-16B244650F16Q33879138-59F846D9-51DF-483C-9F4A-46803F3EFD87Q34810203-569C2433-735F-4A3F-AC92-A33770692468Q34946110-18987EB7-CDAE-493E-BCD0-2D38FC3997ABQ35070934-D6F17636-0C1F-4FE4-96E0-A85D12E36687Q35581407-A4388707-F18A-483E-A88D-EF154A3781D0Q35608778-88F1E5C3-D2E4-4A93-9A31-729AEF70D9AAQ35621906-33AFD3C6-46EC-4DC9-B4AD-516266D47AA1Q35681249-9DE92E9F-B822-4843-8B0E-9951411439ABQ35754084-4E507A27-69EF-44AE-BC3A-81BA046BD9B7Q35791843-EC411D5C-2412-44BB-9C23-DC6C72603391Q36045288-589C8E4D-E9B4-4669-928C-2978D6F32BA4Q36121608-00469212-86B0-4E3D-ACCC-CABE648DB6D8Q36224468-9268CA68-25F1-460F-9B57-5EE23D18F6F4Q36315822-49183417-BC9E-4D05-B166-783C3FDD6556Q36371878-7F402621-4C8B-4F18-B0A0-A54FB1AC7363Q36572684-33161B18-0C44-4693-9BE8-BF3F8097EC93Q36572712-02D6E3E6-8384-4C9A-B4B0-3D6A48ABB0BEQ36573832-8FA4E45E-32E8-4483-A3DF-E94DF41A709EQ36673575-0F98424A-BFBD-441C-A523-D8EB33ACFA01Q36736022-EB379357-D503-428D-BDE0-96DC348DB75BQ36801253-148A212D-C0B4-4138-9EF2-54222352491BQ36818681-137A0A1B-E1C3-4619-8095-732112E52195Q36838747-716D6EAE-C710-4B3C-8B42-C08394A9C7E9Q36879018-52E331AC-DEE6-4069-97B0-D0CC0A9880CAQ36966082-F186D81C-D3C6-47C8-A2CB-0CE09BA29010Q36994850-578A292B-C03E-46CC-9DE5-4887D65E0704Q37010020-E7A15571-C831-48FC-B08E-E2E3C851A68FQ37041995-64C5291F-72AE-4FE4-A9C1-2313BFF8807CQ37115894-2ABAD72E-8537-439F-988F-739D8455E634Q37124549-620DB445-9BA7-4AF2-A797-81D7DAAA77BCQ37235949-B879422F-5A2A-4A3F-8460-0BC4376B516DQ37246788-76F43FFB-D41C-49EF-8821-ECADF114153F
P2860
Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@ast
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@en
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@nl
type
label
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@ast
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@en
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@nl
prefLabel
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@ast
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@en
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@nl
P2093
P1476
Isoprostanes as a biomarker of ...... ogy and clinical implications.
@en
P2093
Germain Bessard
Jean-Luc Cracowski
Thierry Durand
P304
P356
10.1016/S0165-6147(02)02053-9
P577
2002-08-01T00:00:00Z